Focused exclusively on companies defining the healthcare industry, the J.P. Morgan Healthcare Conference is the largest of its kind and will welcome over 400 public and private companies to deliver presentations to over 8,000 attendees, including investor
Gracell Biotechnologies Co., Ltd, a clinical-stage immune cell therapy company, announced the progressive clinical outcomes for leading product candidates FasTCAR-19 ...
Preliminary data shows a high response rate, with 16 of 16 patients achieving complete remission and 14 of 16 patients achieving undetectable minimal residual disease with mild side effect observed